AMPE insider filings
Ampio Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-13. Screen AMPE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for AMPE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Ampio Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-06-13 | 4 | BUCHI J KEVIN — Director | Purchase (P): 21,858 @ $0.29 | EDGAR |
| 2023-06-09 | 4 | BUCHI J KEVIN — Director | Purchase (P): 25,000 @ $0.30 | EDGAR |
| 2023-05-26 | 4 | MARTINO MICHAEL A — CEO, Director | Purchase (P): 76,890 @ $0.29 | EDGAR |
| 2023-05-17 | 4 | BUCHI J KEVIN — Director | Purchase (P): 32,534 @ $0.27 | EDGAR |
| 2023-05-16 | 4 | BUCHI J KEVIN — Director | Purchase (P): 23,440 @ $0.24 · Purchase (P): 44,026 @ $0.25 | EDGAR |
| 2023-05-12 | 4 | Stevens David R — Director | Purchase (P): 25,000 @ $0.22 · Purchase (P): 25,000 @ $0.21 · Purchase (P): 45,000 @ $0.22 | EDGAR |
| 2022-03-02 | 4 | JOBES ELIZABETH VARKI — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2022-02-10 | 4 | Bar-Or David — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Cherevka Holli — PRESIDENT AND COO | Tax withholding (F): 47,200 @ $0.57 | EDGAR |
| 2022-01-04 | 4 | STOKELY DAN — CFO | Tax withholding (F): 22,914 @ $0.57 | EDGAR |
| 2022-01-04 | 4 | MACALUSO MICHAEL — Director | Tax withholding (F): 68,400 @ $0.57 | EDGAR |
| 2022-01-03 | 4 | Giles Richard B — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Stevens David R — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | MARTINO MICHAEL A — INTERIM CHAIRMAN AND CEO, Director | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | BUCHI J KEVIN — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | COELHO PHILIP H — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2021-11-24 | 4 | MARTINO MICHAEL A — INTERIM CHAIRMAN AND CEO, Director | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2021-10-28 | 4 | Cherevka Holli — PRESIDENT AND COO | Tax withholding (F): 41,980 @ $1.64 | EDGAR |
| 2021-10-28 | 4 | STOKELY DAN — CFO | Tax withholding (F): 28,127 @ $1.64 | EDGAR |
| 2021-10-28 | 4 | MACALUSO MICHAEL — CEO, Director | Tax withholding (F): 43,470 @ $1.64 | EDGAR |
| 2021-10-25 | 4 | MARTINO MICHAEL A — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-10-25 | 4 | BUCHI J KEVIN — Director | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | Bar-Or David — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | Giles Richard B — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | Stevens David R — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-10-15 | 4 | COELHO PHILIP H — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2021-10-13 | 4 | Cherevka Holli — CHIEF OPERATING OFFICER | Grant/award (A): 500,000 @ $0 | EDGAR |
| 2021-10-13 | 4 | STOKELY DAN — CFO | Grant/award (A): 335,000 @ $0 | EDGAR |
| 2021-10-13 | 4 | MACALUSO MICHAEL — CEO, Director | Grant/award (A): 950,000 @ $0 | EDGAR |
| 2021-06-29 | 4 | STOKELY DAN — CFO | Option exercise (M): 22,500 @ $0.43 · Sale (S): 22,500 @ $1.79 · Option exercise (M): 22,500 (derivative) @ $0 | EDGAR |
| 2021-05-25 | 4 | Cherevka Holli — CHIEF OPERATING OFFICER | Option exercise (M): 2,603 @ $0.51 · Sale (S): 2,603 @ $2 · Option exercise (M): 2,603 (derivative) @ $0 | EDGAR |
| 2021-05-25 | 4 | COELHO PHILIP H — Director | Option exercise (M): 6,737 @ $0.40 · Sale (S): 6,737 @ $2 · Option exercise (M): 6,737 (derivative) @ $0 | EDGAR |
| 2021-05-19 | 4 | STOKELY DAN — CFO | Option exercise (M): 35,000 @ $0.43 · Sale (S): 35,000 @ $1.83 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2021-04-29 | 4 | Cherevka Holli — CHIEF OPERATING OFFICER | Option exercise (M): 30,000 @ $0.51 · Option exercise (M): 44,631 @ $0.51 · Sale (S): 74,631 @ $2 · Option exercise (M): 30,000 (derivative) @ $0.51 · Option exercise (M): 44,631 (derivative) @ $0.51 | EDGAR |
| 2021-04-29 | 4 | COELHO PHILIP H — Director | Option exercise (M): 20,000 @ $0.40 · Sale (S): 20,000 @ $2 · Option exercise (M): 20,000 (derivative) @ $0.40 | EDGAR |
| 2021-04-29 | 4 | COELHO PHILIP H — Director | Option exercise (M): 3,263 @ $0.40 · Sale (S): 3,263 @ $2 · Option exercise (M): 3,263 (derivative) @ $0.40 | EDGAR |
| 2021-03-17 | 4 | STOKELY DAN — CFO | Option exercise (M): 40,000 @ $0.43 · Sale (S): 40,000 @ $1.83 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | STOKELY DAN — CFO | Option exercise (M): 42,000 @ $2.55 · Option exercise (M): 10,500 @ $2.55 · Tax withholding (F): 24,185 @ $2.55 · Option exercise (M): 42,000 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | Bar-Or David — Director | Grant/award (A): 13,513 @ $1.48 | EDGAR |
| 2021-01-05 | 4 | Giles Richard B — Director | Grant/award (A): 13,513 @ $1.48 | EDGAR |
| 2021-01-05 | 4 | Stevens David R — Director | Grant/award (A): 13,513 @ $1.48 | EDGAR |
| 2021-01-05 | 4 | COELHO PHILIP H — Director | Grant/award (A): 13,513 @ $1.48 | EDGAR |
| 2020-12-21 | 4 | Cherevka Holli — CHIEF OPERATING OFFICER | Grant/award (A): 10,000 (derivative) @ $0 · Disposition to issuer (D): 70,598 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2020-12-21 | 4 | STOKELY DAN — CFO | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2020-12-21 | 4 | MACALUSO MICHAEL — CEO, Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2020-12-15 | 4 | Giles Richard B — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2020-12-15 | 4 | Bar-Or David — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2020-12-15 | 4 | Stevens David R — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2020-12-15 | 4 | COELHO PHILIP H — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2020-11-18 | 4 | Bar-Or David — Director | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Ampio Pharmaceuticals, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-01-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-03-25 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-28 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-01-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AMPE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs